[go: up one dir, main page]

AU5316999A - Use of nucleic acid molecules as antiviral agents - Google Patents

Use of nucleic acid molecules as antiviral agents

Info

Publication number
AU5316999A
AU5316999A AU53169/99A AU5316999A AU5316999A AU 5316999 A AU5316999 A AU 5316999A AU 53169/99 A AU53169/99 A AU 53169/99A AU 5316999 A AU5316999 A AU 5316999A AU 5316999 A AU5316999 A AU 5316999A
Authority
AU
Australia
Prior art keywords
nucleic acid
acid molecules
antiviral agents
antiviral
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53169/99A
Inventor
Leonid Beigelman
Laurent Bellon
Cheng C. Kao
Robert W. Siegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Indiana University Research and Technology Corp
Original Assignee
Indiana University Research and Technology Corp
Ribozyme Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indiana University Research and Technology Corp, Ribozyme Pharmaceuticals Inc filed Critical Indiana University Research and Technology Corp
Publication of AU5316999A publication Critical patent/AU5316999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/332—Abasic residue

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU53169/99A 1998-07-20 1999-07-15 Use of nucleic acid molecules as antiviral agents Abandoned AU5316999A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9348998P 1998-07-20 1998-07-20
US60093489 1998-07-20
US17951698A 1998-10-26 1998-10-26
US09179516 1998-10-26
PCT/US1999/016253 WO2000004141A2 (en) 1998-07-20 1999-07-15 Use of nucleic acid molecules as antiviral agents

Publications (1)

Publication Number Publication Date
AU5316999A true AU5316999A (en) 2000-02-07

Family

ID=26787599

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53169/99A Abandoned AU5316999A (en) 1998-07-20 1999-07-15 Use of nucleic acid molecules as antiviral agents

Country Status (5)

Country Link
EP (1) EP1098969A2 (en)
JP (1) JP2002520051A (en)
AU (1) AU5316999A (en)
CA (1) CA2334161A1 (en)
WO (1) WO2000004141A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125660B2 (en) 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
US7294457B2 (en) * 2001-08-07 2007-11-13 Boehringer Ingelheim (Canada) Ltd. Direct binding assay for identifying inhibitors of HCV polymerase
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
HRP20090250T1 (en) 2004-02-24 2009-06-30 Japan Tobacco CONDENSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS HCV POLYMERASE INHIBITORS
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2226728A1 (en) * 1995-07-13 1997-03-20 Michael G. Zwick Compositions and method for modulation of gene expression in plants
CA2253382A1 (en) * 1996-01-16 1997-07-24 Ribozyme Pharmaceuticals, Inc. Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
GB9615349D0 (en) * 1996-07-22 1996-09-04 Zeneca Ltd Virus resistance in plants
US6500652B2 (en) * 1998-03-26 2002-12-31 Advanced Research And Technology Institute, Inc. Use of nucleic acid molecules as antiviral agents

Also Published As

Publication number Publication date
EP1098969A2 (en) 2001-05-16
CA2334161A1 (en) 2000-01-27
JP2002520051A (en) 2002-07-09
WO2000004141A2 (en) 2000-01-27
WO2000004141A3 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
AU5926598A (en) Electronic-property probing of biological molecules at surfaces
AU5584999A (en) System for the rapid manipulation of nucleic acid sequences
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
AU3199699A (en) Modified nucleotides and methods useful for nucleic acid sequencing
AU3699899A (en) Method for conducting the synthesis of nucleic acid molecules
AU4003800A (en) Electrokinetic concentration of charged molecules
AU1450699A (en) Methods of nucleic acid detection
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
EP1144682A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU5128499A (en) Dynamic model of the dna molecule
AU6024599A (en) Synthesis of phosphonomethyliminodiacetic acid with reduced effluent
AU5316999A (en) Use of nucleic acid molecules as antiviral agents
GB9717932D0 (en) Estimation of nucleic acid
AU2180000A (en) Nucleic acid molecules of shrimp
AU3210199A (en) Use of nucleic acid molecules as antiviral agents
HK1034285A (en) Use of nucleic acid molecules as antiviral agents
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor
AU4826899A (en) Novel msp-5 protein and nucleic acid molecules and uses therefor
AU1354201A (en) Compositions and methods of synthesis and use of novel nucleic acid structures
AU2567601A (en) Enrichment of nucleic acid
AU7343398A (en) Diphenylacetic acid derivatives and their use as antiviral agents
AU3355600A (en) Isolation of nucleic acid molecules
AU5582899A (en) Formamides as therapeutic agents
AU6519999A (en) Isolated proteins and nucleic acid molecules having homology to the nip2 proteinand uses thereof
AUPP372698A0 (en) Novel nucleic acid molecules and uses therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase